All Stories

  1. Structural, supramolecular analysis, and photoluminescence properties of a new hydroxybenzohydrazide Schiff base
  2. Manganese‐Induced Production of Antioxidant Polyene Steroids in the Extremophile Fungus Talaromyces fuscoviridis Isolated From Copper‐Mine Soil
  3. New Naphthoquinone‐Based Manganese (II) Complexes: Synthesis, Characterization, and Cytotoxicity
  4. Use of computational techniques in Raman spectra analysis
  5. Ascorbyl Radicals as Reducing Agents in Copper-Catalyzed Redox Reactions
  6. The Vortex-Slurry Implementation: A Cheap, Easy, and Ultrafast Mechanochemical Tool to Synthesize/Screen Pharmaceutical Salts and Cocrystals
  7. A supersaturated glass-melt approach for growing micrometer-sized TGG single crystals
  8. Enhanced Anticancer Potential of Pd(II)-Thiosemicarbazone Complexes: Selectivity, Mechanisms, and 3D Models
  9. Innovative synthesis of Tm³⁺/Er³⁺-doped Yb-YGG single crystals for upconversion-based white light emission
  10. Ru(II)-Fenamic-Based Complexes as Promising Human Ovarian Antitumor Agents: DNA Interaction, Cellular Uptake, and Three-Dimensional Spheroid Models
  11. A new anthelmintic salt
  12. Enhancing physicochemical properties of hydrochlorothiazide with zwitterionic L-proline and 5-fluorocytosine cocrystals through mechanochemical synthesis
  13. Ruthenium(II) Complex with 1-Hydroxy-9,10-Anthraquinone Inhibits Cell Cycle Progression at G0/G1 and Induces Apoptosis in Melanoma Cells
  14. A novel imatinib analogue inhibitor of chronic myeloid leukaemia: design, synthesis and characterization—explanation of its folded conformation
  15. A nickel glutamate metal biomolecule framework
  16. Dual spectral and temporal encoding in luminescent polymeric films using a EuIII complex and a persistent phosphor for anti-counterfeiting applications
  17. Reactions of ketosulfoxonium ylides with allylic carbocations: stereoselective and direct access to highly-substituted cyclo-propanes and α-alkylated ylides
  18. Diastereoselective Synthesis of Highly Functionalized γ‐Lactams via Ugi Reaction/Michael Addition
  19. A new ciprofibrate calcium salt with improved solubility and intrinsic dissolution rate
  20. NMR and X-ray diffraction conformational study of guanidines
  21. Synthesis, XRD structural analysis and theoretical studies of a potential inhibitor against rheumatoid arthritis (RA)
  22. Reactivity of the p‐Cymene‐Ruthenium Complex with Two Phenylamines for Metathesis Polymerization of Norbornene Compared to the Reactivity of Complexes with a Single Benzylamine or Dibenzylamine
  23. Structural Properties and Charge Redistribution in Cocrystallized Pharmaceutical Ingredients: A Comparative Experimental and Theoretical Charge Density Analysis
  24. Synthesis, characterization and structural analysis of complexes from 2,2′:6′,2′′-terpyridine derivatives with transition metals
  25. Controlled synthesis and structure characterization of a new fluconazole polymorph using analytical techniques and multivariate method
  26. Study of the Conformation of Bromated Guanidines with Potential Anti-leishmania Activity
  27. Use of Mechanochemical Methodology to Explore the Formation of a New Crystalline Phase in the Curcumin‐Quercetin System
  28. Intensity and lifetime ratiometric luminescent thermometer based on a Tb(iii) coordination polymer
  29. Versatile Applications of Cyanoacetic Acid in Organic Chemistry: Active Methylene Compound for the Knoevenagel Condensation and Organocatalyst for the Biginelli Reaction
  30. Structural and Anticancer Studies of Methoxyflavone Derivative from Strychnos pseudoquina A.St.-Hil. (Loganiaceae) from Brazilian Cerrado
  31. Synthesis, Characterization, DNA Binding and Cytotoxicity of Copper(II) Phenylcarboxylate Complexes
  32. Synthesis, Characterization and Structural Analysis of Two New Biguanide Complexes
  33. Crystalline and amorphous famotidine malate as pathways to prevent polymorphic transformation with improved dissolution
  34. Nitrosyl/Diphenylphosphine/Amino Acid–Ruthenium Complexes as Inhibitors of MDA-MB-231 Breast Cancer Cells
  35. Molecular structure of Ru(II)/diphosphine/4,6-dimethyl-2-pyrimidinethiol complexes: A combined experimental and density functional theory study
  36. Drug Repurposing of the Antiviral Drug Acyclovir: New Pharmaceutical Salts
  37. Development of Copper Complexes with Diimines and Dipicolinate as Anticancer Cytotoxic Agents
  38. “Half-Sandwich” Ruthenium Complexes with Alizarin as Anticancer Agents: In Vitro and In Vivo Studies
  39. Tuning the Thermometric Features in 1D Luminescent EuIII and TbIII Coordination Polymers through Different Bridge Phosphine Oxide Ligands
  40. It Takes Two to Tango, Part II: Synthesis of A-Ring Functionalised Quinones Containing Two Redox-Active Centres with Antitumour Activities
  41. New Copper(II)-L-Dipeptide-Bathophenanthroline Complexes as Potential Anticancer Agents—Synthesis, Characterization and Cytotoxicity Studies—And Comparative DNA-Binding Study of Related Phen Complexes
  42. Spontaneous Resolution of RS-Fluoxetine to a Racemic Conglomerate upon Salt Formation with Oxalic Acid
  43. Activation–Deactivation of Inter-Peptide Bond in Fluoro-N-(2-hydroxy-5-methyl phenyl)benzamide Isomers, Induced by the Position of the Halogen Atom in the Benzene Ring
  44. Highlighting Recent Crystalline Engineering Aspects of Luminescent Coordination Polymers Based on F-Elements and Ditopic Aliphatic Ligands
  45. Synthesis and Evaluation of Antibacterial Activity of 1,2,3-Triazole and Ether Derivatives of Paeonol
  46. Roméite-Group Minerals Review: New Crystal Chemical and Raman Data of Fluorcalcioroméite and Hydroxycalcioroméite
  47. Vibrational and conformational analysis of structural phase transition in Estradiol 17β valerate with temperature
  48. Estudio estructural y supramolecular del ácido 2-E-((4-hidroxifenil) diazenil) benzoico
  49. Crystal Engineering in the design of New Solid Pharmaceutical Forms with enhanced pharmaceutical properties
  50. Amino–Imino Tautomerism in the Salt Formation of Albendazole: Hydrobromide and Nitrate Salts
  51. Glycosylated narciclasine alkaloid in Hippeastrum puniceum (Lam.) Kuntze
  52. Synthesis and X-ray crystal structures of polyfunctionalized 4H-chromene derivatives via tricomponent reaction with Knoevenagel adducts as intermediates in aqueous medium
  53. Molecular Structure Studies on Allyl Sulfonamides: Synthesis, Theoretical Treatment and Evaluation of Biological Activity
  54. meso-Tetra-(4-pyridyl)porphyrin/palladium(ii) complexes as anticancer agents
  55. Study of secondary porosity by SAXS and N 2 adsorption in composite materials obtained from a Cuban natural clinoptilolite
  56. Silver complexes with fluoroanthranilic acid isomers: Spectroscopic characterization, antimycobacterial activity and cytotoxic studies over a panel of tumor cells
  57. Synthesis and structural characterization of a series of ternary copper(II)-L-dipeptide-neocuproine complexes. Study of their cytotoxicity against cancer cells including MDA-MB-231, triple negative breast cancer cells
  58. Zeolite/ZnO composites based on a Cuban natural clinoptilolite and preliminary evaluation in methylene blue adsorption
  59. Biguanide–transition metals complexes as potential drug for hyperglycemia treatment
  60. Chain-like uranyl-coordination polymer as a bright green light emitter for sensing and sunlight driven photocatalysis
  61. Chemical transformation of a luminescent two-dimensional Eu(iii) coordination polymer in the aqueous phase
  62. Crystal structure, anti-Trypanosoma cruzi and cytotoxic activities of Cu(II) complexes bearing β-diketone and α-diimine ligands
  63. New Allyldithiocarbimates: Synthesis, Structure and Antifungal Activity against Phakopsora pachyrhizi and Hemileia vastatrix
  64. Synthesis and solid-state characterization of diclofenac imidazolium monohydrate: an imidazolium pharmaceutical ionic liquid
  65. “Half-Sandwich”/RuII Anticancer Complexes Containing Triphenylphosphine and p-Substituted Benzoic Acids
  66. Silver(i) complexes of 3-methoxy-4-hydroxybenzaldehyde thiosemicarbazones and triphenylphosphine: structural, cytotoxicity, and apoptotic studies
  67. Rational design, supramolecular synthesis and solid state characterization of two bicomponent solid forms of mebendazole
  68. Green One-Pot Asymmetric Synthesis of Peptidomimetics via Sequential Organocatalyzed Aziridination and Passerini Multicomponent Reaction
  69. Data of synthesis, characterization and luminescence measurements in 1D lanthanide coordination polymers based on lanthanides
  70. Synthesis, spectroscopic (FT–IR and UV–Vis), crystallographic and theoretical studies, and a molecular docking simulation of an imatinib-like template
  71. Green Synthetic Methodology of (E)-2-cyano-3-aryl Selective Knoevenagel Adducts Under Microwave Irradiation
  72. Ru(II) complexes containing uracil nucleobase analogs with cytotoxicity against tumor cells
  73. THERMAL BEHAVIOR OF INOSINE 5’-MONOPHOSPHATE COMPLEXES WITH COBALT(II), NICKEL(II), COPPER(II) AND CADMIUM(II) CATIONS
  74. Crystal structures of two CuII compounds: catena-poly[[chloridocopper(II)]-μ-N-[ethoxy(pyridin-2-yl)methylidene]-N′-[oxido(pyridin-3-yl)methylidene]hydrazine-κ4 N,N′,O:
  75. 1D lanthanide coordination polymers based on lanthanides and 4′-hydroxi-4-biphenylcarboxylic acid: Synthesis, structures and luminescence properties
  76. Synthesis, structural characterization, and theoretical studies of new pyrazole (E)-2-{[(5-(tert-butyl)-1H-pyrazol-3-yl)imino]methyl}phenol and (E)-2-{[(1-(4-bromophenyl)-3-(tert-butyl)-1H-pyrazol-5-yl]imino]methyl}phenol
  77. Isolation, Identification, Predictions of Biological Activity and Molecular Docking of the Diterpene Jateorin Obtained from the Stem of Odontocarya tamoides (D.C.) Miers
  78. A simple alternative to prodrug: The hydrochloride salt monohydrate of the prostate anticancer drug abiraterone
  79. Ru(II)/N-N/PPh3 complexes as potential anticancer agents against MDA-MB-231 cancer cells (N-N = diimine or diamine)
  80. Nickel complexes with phosphines and N-R-sulfonyldithiocarbimates ligands: New antifungals for the control of Hemileia vastatrix and Phakopsora pachyrhizi
  81. Fluconazole: Synthesis and Structural Characterization of Four New Pharmaceutical Cocrystal Forms
  82. Esterification of the free carboxylic group from the lutidinic acid ligand as a tool to improve the cytotoxicity of Ru(ii) complexes
  83. X-ray diffraction, vibrational and thermal study of dibenzazepinodione, a pharmacopeial impurity of oxcarbazepine
  84. Fluconazolium oxalate: synthesis and structural characterization of a highly soluble crystalline form
  85. When Serendipity Knocks on the Door: Synthesis and Physicochemical Characterization of 7-Chloro-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidin-5-one
  86. Pharmaceutical paroxetine-based organic salts of carboxylic acids with optimized properties: the identification and characterization of potential novel API solid forms
  87. Supramolecular synthesis and characterization of crystalline solids obtained from the reaction of 5-fluorocytosine with nitro compounds
  88. Highly water soluble agrichemicals by using engineered organic salts for reducing adverse environmental impacts
  89. APLICAÇÃO DA ESPECTROSCOPIA RAMAN NA CARACTERIZAÇÃO DE MINERAIS PERTENCENTES A UMA GEOCOLEÇÃO
  90. In vitro Antiplasmodial Activities of Alkaloids Isolated from Roots of Worsleya procera (Lem.) Traub (Amaryllidaceae)
  91. In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
  92. In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes
  93. Spergulagenic Acid A: Isolation and single crystal structure elucidation
  94. Modulating the water solubility and thermal stability of the anti-tuberculosis drug Isoniazid via multicomponent crystal formation
  95. Development of copper(II)-diimine-iminodiacetate mixed ligand complexes as potential antitumor agents
  96. The use of variable temperature 13 C solid-state MAS NMR and GIPAW DFT calculations to explore the dynamics of diethylcarbamazine citrate
  97. In vitro leishmanicidal activity and theoretical insights into biological action of ruthenium(II) organometallic complexes containing anti-inflammatories
  98. Rational Design of a Famotidine–Ibuprofen Coamorphous System: An Experimental and Theoretical Study
  99. Crystal Structure of N-(2-Cyano-1-Phenylprop-2-en-1-yl)-4-Methylbenzenesulfonamide
  100. Mechanochemical Synthesis of a Multicomponent Solid Form: The Case of 5-Fluorocytosine Isoniazid Codrug
  101. Synthesis, crystal structure, photophysical properties and theoretical studies of a novel bis(phenylisoxazolyl) benzene derivative
  102. Co-crystal structure of a dinuclear (Zn-Y) and a trinuclear (Zn-Y-Zn) complexes derived from a Schiff base ligand
  103. 5-Fluorocytosine/5-Fluorouracil Drug-Drug Cocrystal: a New Development Route Based on Mechanochemical Synthesis
  104. Protonation of inorganic 5-Fluorocytosine salts
  105. Synthesis, characterization and solubility of a new anthelmintic salt: Mebendazole nitrate
  106. Novel Solid Solution of the Antiretroviral Drugs Lamivudine and Emtricitabine
  107. Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes
  108. Paroxetine and Fluoxetine Hexafluorosilicate salts: Synthesis, crystal structure, Hirshfeld surface, and supramolecular analysis
  109. {1-[1-(2-Hydroxyphenyl)ethylidene]-2-(pyridin-2-yl-κN)hydrazine-κ2 N′,O}{1-[1-(2-oxidophenyl)ethylidene]-2-(pyridin-2-yl-κN)hydrazine-κ2 N′,O}nickelate(...
  110. Antimicrobial activity of cis -[Ru(bpy) 2 (L)(L′)] n + complexes, where L = 4-(4-chlorobenzoyl)pyridine or 4-(benzoyl)pyridine and L′ = Cl − or CO
  111. Crystalline structure of the marketed form of Rifampicin: a case of conformational and charge transfer polymorphism
  112. Novel Isoniazid cocrystals with aromatic carboxylic acids: Crystal engineering, spectroscopy and thermochemical investigations
  113. Ru(ii)–thyminate complexes: new metallodrug candidates against tumor cells
  114. A vanillin-based copper(ii) metal complex with a DNA-mediated apoptotic activity
  115. Avoiding irreversible 5-fluorocytosine hydration via supramolecular synthesis of pharmaceutical cocrystals
  116. Facile Synthesis and Characterization of Symmetric N-[(Phenylcarbonyl) carbamothioyl]benzamide Thiourea: Experimental and Theoretical Investigations
  117. Exploring physical and chemical properties in new multifunctional indium-, bismuth-, and zinc-based 1D and 2D coordination polymers
  118. Crystal engineering of multicomponent crystal forms of antituberculosis drugs
  119. Crystallochemical characterization of polyoxometalate new minerals
  120. Synthesis, characterization and reactivity of halides/pseudohalides and their complexes containing ruthenium II in the hydrogenation of cyclohexene
  121. Conformational and structural diversity of iridium dimethyl sulfoxide complexes
  122. Probing intermolecular interactions in a diethylcarbamazine citrate salt by fast MAS 1 H solid-state NMR spectroscopy and GIPAW calculations
  123. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells
  124. Spectroscopic (far or terahertz, mid-infrared and Raman) investigation, thermal analysis and biological activity of piplartine
  125. Synthesis, structural characterization and cytotoxic activity against tumor cells of heteroleptic copper (I) complexes with aromatic diimines and phosphines
  126. Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation
  127. Photochemical studies of cis -[Ru(bpy) 2 (4-bzpy)(CO)](PF 6 ) 2 and cis -[Ru(bpy) 2 (4-bzpy)(Cl)](PF 6 ): Blue light-induced nucleobase binding
  128. Ruthenium(II)/triphenylphosphine complexes: An effective way to improve the cytotoxicity of lapachol
  129. Development of a salt drug with improved solubility: Ethionamide nitrate
  130. Propyl gallate metal complexes: Circular dichroism, BSA-binding, antioxidant and cytotoxic activity
  131. Hydroxycalciomicrolite, Ca1.5Ta2O6(OH), a new member of the microlite group from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  132. Reducing the Hygroscopicity of the Anti-Tuberculosis Drug (S,S)-Ethambutol Using Multicomponent Crystal Forms
  133. Reactive nitrogen/oxygen species production by nitro/nitrosyl supramolecular ruthenium porphyrin complexes
  134. Copper(I)–Phosphine Polypyridyl Complexes: Synthesis, Characterization, DNA/HSA Binding Study, and Antiproliferative Activity
  135. Syntheses, characterization and antifungal activity of novel dimethylbis(N-R-sulfonyldithiocarbimato)stannate(IV) complexes
  136. Order–disorder phase transition induced by proton transfer in a co-crystal of 2,4-dichlorobenzoic acid and trimethylamine N-oxide
  137. A Potential Visible-Light NO Releaser: Synthesis, Reactivity and Vasodilator Properties
  138. Polypyridyl Ruthenium Complexes: Novel DNA-Intercalating Agents against Human Breast Tumor
  139. Structural isomerism of Ru(ii)-carbonyl complexes: synthesis, characterization and their antitrypanosomal activities
  140. Studies on the Ru(II) monocationic complexes [RuCl 2 (NO)(P–N)(PR 3 )]PF 6 , where P–N = o -diphenylphosphino- N , N -dimethylaniline, and R = Ph and p -X-C 6 H 4 (X = OMe, Me, F)
  141. Ru(II)/bisphosphine/diimine/amino acid complexes: diastereoisomerism, cytotoxicity, and inhibition of tumor cell adhesion to collagen type I
  142. Correction to Rare Case of Polymorphism in a Racemic Fluoxetine Nitrate Salt: Phase Behavior and Relative Stability
  143. Solution and Solid State Nuclear Magnetic Resonance Spectroscopic Characterization of Efavirenz
  144. X-Ray diffraction, spectroscopy and thermochemical characterization of the pharmaceutical paroxetine nitrate salt
  145. Diffractaic acid: Crystalline structure and physicochemical characterization
  146. On the Thermal Stability of the Diethylcarbamazine-Fortified Table Salt Used in the Control of Lymphatic Filariasis
  147. Rare Case of Polymorphism in a Racemic Fluoxetine Nitrate Salt: Phase Behavior and Relative Stability
  148. Centrosymmetric resonance-assisted intermolecular hydrogen bonding chains in the enol form of β-diketone: Crystal structure and theoretical study
  149. Syntheses, characterization and antifungal activity of heteroleptic nickel(II) complexes with N-alkylsulfonyldithiocarbimates and phosphines
  150. Cationic Pd(II) complexes acting as topoisomerase II inhibitors: Synthesis, characterization, DNA interaction and cytotoxicity
  151. Reversible Solid-State Hydration/Dehydration of Paroxetine HBr Hemihydrate: Structural and Thermochemical Studies
  152. Looking for the interactions between omeprazole and amoxicillin in a disordered phase. An experimental and theoretical study
  153. Tetraphenylphosphonium allyldithiocarbimates derived from Morita-Baylis-Hillman adducts: Synthesis, characterization, crystal structure and antifungal activity
  154. Tuning the structure, dimensionality and luminescent properties of lanthanide metal–organic frameworks under ancillary ligand influence
  155. Supramolecular synthesis and thermochemical investigations of pharmaceutical inorganic isoniazid salts
  156. Rare earth coordination dinuclear compounds constructed from 3,5-dicarboxypyrazolate and succinate intermetallic bridges
  157. Influence of gold nanoparticles applied to catalytic hydrogenation of acetophenone with cationic complexes containing ruthenium
  158. Mechanochemistry applied to reformulation and scale-up production of Ethionamide: Salt selection and solubility enhancement
  159. Luminescence, chemical sensing and mechanical properties of crystalline materials based on lanthanide–sulfonate coordination polymers
  160. Chiral Platinum(II) Complexes Featuring Phosphine and Chloroquine Ligands as Cytotoxic and Monofunctional DNA-Binding Agents
  161. Crystal structure of 4-formyl-2-nitrophenyl 4-chloro-2-nitrobenzoate
  162. Crystal structure of 2-(4-chlorobenzamido)benzoic acid
  163. Cis-[RuCl(BzCN)(N–N)(P–P)]PF6 complexes: Synthesis and in vitro antitumor activity
  164. Vibrational and thermal analyses of multicomponent crystal forms of the anti-HIV drugs lamivudine and zalcitabine
  165. Exploring the System Lanthanide/Succinate in the Formation of Porous Metal–Organic Frameworks: Experimental and Theoretical Study
  166. Crystal structure and catalytic activity of ruthenium (II)/dithiocarbamate complexes in the epoxidation of cyclooctene
  167. Copper(II) complexes with β-diketones and N-donor heterocyclic ligands: Crystal structure, spectral properties, and cytotoxic activity
  168. Isostructurality and the conformational role of the 2′,3′-moieties in the diversity of lamivudine crystal forms probed in halide salts
  169. Anti-Mycobacterium tuberculosisand Cytotoxicity Activities of Ruthenium(II)/Bipyridine/Diphosphine/Pyrimidine-2-thiolate Complexes: The Role of the Non-CoordinatedN-Atom
  170. Ruthenium(II) complexes with hydroxypyridinecarboxylates: Screening potential metallodrugs against Mycobacterium tuberculosis
  171. Crystal Growth & Design Celebrates the International Year of Crystallography 2014
  172. DFT investigation on hydrogen bonding in cyclohexane-1,2,3,4,5-pentol crystal structure
  173. Crystal structure of 4-bromo-N-(2-hydroxyphenyl)benzamide
  174. Crystal structure of 2-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide
  175. Crystal structure of (±)-3-[(benzo[d][1,3]dioxol-5-yl)methyl]-2-(3,4,5-trimethoxyphenyl)-1,3-thiazolidin-4-one
  176. Temperature-Driven Isosymmetric Reversible Phase Transition of the Hormone Estradiol 17β Valerate
  177. Solid-State Supramolecular Synthesis Based on the N–H…O Heterosynthon: An Approach to Solve the Polymorphism Problem in Famotidine
  178. Saddle-shaped macrocycle distortion and symmetry decrease in cobalt (II) meso-tetraphenylporphyrin: Structure of a dichloromethane solvate and DFT calculations
  179. Effect of the Methanol Molecule on the Stabilization of C 18 H 18 O 4 Crystal: Combined Theoretical and Structural Investigation
  180. Structural features and cytotoxic activities of [Ru(AA-H)(dppb)(bipy)]PF6 complexes
  181. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)–dipeptide–phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer
  182. Controlled Synthesis of New 5-Fluorocytosine Cocrystals Based on the p K a Rule
  183. Nitro/Nitrosyl-Ruthenium Complexes Are Potent and Selective Anti-Trypanosoma cruzi Agents Causing Autophagy and Necrotic Parasite Death
  184. Modified glassy carbon electrode with AuNPs using cis-[RuCl(dppb)(bipy)(4-vpy)]+ as crossed linking agent
  185. Antiparasitic activities of novel ruthenium/lapachol complexes
  186. fac-[1,2-Bis(pyridin-4-yl)ethane-κN]tricarbonyl(1,10-phenanthroline-κ2N,N′)rhenium(I) hexafluoridophosphate acetonitrile monosolvate
  187. [4-(Allyloxy)phenyl](phenyl)methanone
  188. 2,4,6-Trinitrophenyl 3-bromobenzoate
  189. 2-[(1-Oxidopyridin-4-yl)sulfanyl]benzoic acid
  190. 3-(Diphenylamino)isobenzofuran-1(3H)-one
  191. Synthesis, characterization and phytotoxic activity of hydroxylated isobenzofuran-1(3H)-ones
  192. Halogen⋯halogen contacts for the stabilization of a new polymorph of 9,10-dichloroanthracene
  193. 2,2′-(1,4-Phenylene)bis(propane-2,2-diyl) bis(benzodithioate)
  194. Quasi-enantiomeric single-nucleoside and quasi-racemic two-nucleoside hydrochloride salts and ruthenium complexes of cytidine and 2′,3′-dideoxycytidine analogs unveiling the negligible structure-driving role of the 2′,3′-moieties
  195. Unusual hydrogen bond patterns contributing to supramolecular assembly: conformational study, Hirshfeld surface analysis and density functional calculations of a new steroid derivative
  196. Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole
  197. Ruthenium(II)/4,6-dimethyl-2-mercaptopyrimidine complexes: Synthesis, characterization, X-ray structures and in vitro cytotoxicity activities on cancer cell lines
  198. Structural and vibrational study of 8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone – A potential metal–protein attenuating compound (MPAC) for the treatment of Alzheimer’s disease
  199. 4-Formyl-2-nitrophenyl 2-chlorobenzoate
  200. The Continuum in 5-Fluorocytosine. Toward Salt Formation
  201. Mebendazole Mesylate Monohydrate: A New Route to Improve the Solubility of Mebendazole Polymorphs
  202. Fluorcalciomicrolite, (Ca, Na, 〈)2Ta2O6F, a new microlite-group mineral from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  203. The effect of guest molecules on the conformation and molecular assembly of the fac-[RuCl3(NO)(dppb)] complex
  204. NH⋯Br, Br⋯π and π⋯π interactions toward self-assembly of the cytosine hydrobromide: Crystal structure, infrared spectroscopy and thermal behavior
  205. 2-[1′-(Benzyloxy)spiro[indane-1,2′-pyrrolidine]-5′-yl]acetonitrile
  206. (±)-3-(5-Amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-benzofuran-1(3H)-one
  207. Industrial Scale Isolation, Structural and Spectroscopic Characterization of Epiisopiloturine from Pilocarpus microphyllus Stapf Leaves: A Promising Alkaloid against Schistosomiasis
  208. 2,4,6-Trinitrophenyl 3-chlorobenzoate
  209. Supramolecular study, Hirshfeld analysis and theoretical study of 6-methoxyquinolineN-oxide dihydrate
  210. 4-Formyl-2-nitrophenyl 4-bromobenzoate
  211. X-ray Crystal Structures of Intermediates of the Stereoselective (±)-Grandisol Synthesis Based on the Remote Alkylation Protocol
  212. 2,2′-(Carbonothioyldisulfanediyl)bis(2-methylpropanoic acid)
  213. Synthesis, crystal structure and photoluminescence of a binuclear complex of europium(III) containing 3,5-dicarboxypyrazolate and succinate
  214. 2,4,6-Trinitrophenyl 4-chlorobenzoate
  215. 5-Chloroquinolin-8-yl furan-2-carboxylate
  216. Study of a series of cobalt(II) sulfonamide complexes: Synthesis, spectroscopic characterization, and microbiological evaluation against M. tuberculosis. Crystal structure of [Co(sulfamethoxazole)2(H2O)2]·H2O
  217. New ruthenium(II)/phosphines/diimines complexes: Promising antitumor (human breast cancer) and Mycobacterium tuberculosis fighting agents
  218. A new copper(II) complex with 2-thenoyltrifluoroacetone and 2,2-bipyridine: Crystal structure, spectral properties and cytotoxic activity
  219. Electrochemical and Monte Carlo studies of self-assembled trans-[Fe(cyclam)(NCS)2]+ complex ion on gold surface as electrochemical sensor for nitric oxide
  220. Hydrokenomicrolite, ( ,H2O)2Ta 2(O,OH)6(H2O), a new microlite-group mineral from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  221. cis-Bis(1,10-phenanthroline-κ2N,N′)bis(pyridin-4-amine-κN1)ruthenium(II) bis(hexafluoridophosphate)
  222. cis-Bis(2,2′-bipyridine-κ2N,N′)bis(pyridin-4-amine-κN1)ruthenium(II) bis(hexafluoridophosphate) acetonitrile monosolvate
  223. Understanding the Solid Forms of 5E-phenylethenylbenzofuroxan with Differentin vivoanti-T. cruziActivity
  224. 16α-Hydroxyfriedelin and 3-Oxo-16-methylfriedel-16-ene as Building Blocks: Crystal Structure and Hirshfeld Surfaces Decoding Intermolecular Contacts
  225. Novel sesquiterpene lactones from Eremanthus seidelii
  226. Crystal Structure of Limonoid 6-O-Acetylswietephragmin E and Theoretical Study of Nuclear Magnetic Resonance Spectra of Phragmalin Limonoids
  227. 3,5-Bis(benzyloxy)benzoic acid
  228. 2,4,6-Trinitrophenyl 4-methylbenzoate
  229. Base-Paired and Base-Stacked Structures of the Anti-HIV Drug Lamivudine: A Nucleoside DNA-Mimicry with Unprecedented Topology
  230. Synthesis, crystal structure and magnetic properties of the helical oxalate-bridged copper(II) chain {[(CH3)4N]2[Cu(C2O4)2] · H2O}n
  231. Ethyl 2-(3-phenylthioureido)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate
  232. Synthesis and characterization of [Ru(η6-C10H14)(dppf)X][PF6] (X=Cl, Br, I, SnF3) compounds: The X-ray structure of [Ru(η6-C10H14)(dppf)Cl][SnCl3]·0.45CH2Cl2
  233. 2,4,6-Trinitrophenyl 3-methylbenzoate
  234. 6-Bromopyridine-2-carbaldehyde phenylhydrazone
  235. Lamivudine Salts with Improved Solubilities
  236. 9-(4-Bromobutyl)-9H-carbazole
  237. Synthesis and characterization of the atropisomeric relationships of a substituted N-phenyl-bipyrazole derivative with anti-inflammatory properties
  238. Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor
  239. Cyclopropane- and spirolimonoids and related compounds from Hortia oreadica
  240. Host–guest interactions between xanthones and water: the role of O–H···O, C–H···O, and π···π contacts in the channel- and cage-type frameworks
  241. Pseudopolymorphism in hydroxybenzophenones: the dihydrate of 2,2′,4,4′-tetrahydroxybenzophenone
  242. Influence of hydrogen bonds on the molecular structure and conformations of two (C30H48O2) pentacyclic triterpene isomers
  243. Salts of the anti-HIV drug lamivudine with phthalic and salicylic acids
  244. Toward supramolecular architectures of the anti-HIV drug lamivudine: understanding the effect of the inclusion of water in a hydrochloride form
  245. Form III-like conformation and Form I-like packing in a chloroform channel solvate of the diuretic drug chlortalidone
  246. X-ray diffraction and theoretical investigation of the Gedunin crystal structure
  247. Preparation, characterization and structure of ruthenium phosphine complexes containing non-innocent ligands
  248. Hydrothermal syntheses of ETS-10 like vanadosilicates using chiral organic molecules. Part I
  249. 4-Methylphenyl 4-bromobenzoate
  250. Ruthenium(II) phosphine/diimine/picolinate complexes: Inorganic compounds as agents against tuberculosis
  251. Syntheses, crystal structure and theoretical investigation of novel heteroleptic complexes of nickel(II) with N-R-sulfonyldithiocarbimate and phosphine ligands
  252. Rankamaite from the Urubu pegmatite, Itinga, Minas Gerais, Brazil: Crystal chemistry and Rietveld refinement
  253. Weak C—H...Cl—Pd interactions toward conformational polymorphism intrans-dichloridobis(triphenylphosphane)palladium(II)
  254. A monoclinic polymorph of the ticlopidine hydrochloride
  255. Crystal structure of the drug diethylcarbamazine and a new maleate salt
  256. Supramolecular chemistry of anti-HIV nucleoside drugs: toward smart crystal phases and self-assembled DNA-mimicries
  257. Asymmetric heterobimetallic mixed-valence complex trans-[(SO3)Co(cyclam)(NCS)Ru(NH3)4(NCS)](BF4): Synthesis and characterization
  258. Experimental and theoretical investigation of molecular structure and conformation of the 4-isopropylthioxanthone
  259. fac-/mer-[RuCl3(NO)(P–N)] (P–N=[o-(N,N-dimethylamino)phenyl]diphenylphosphine): Synthesis, characterization and DFT calculations
  260. Conformational polymorphism of the antidiabetic drug chlorpropamide
  261. cis-Bis[1,1-dibenzyl-3-(furan-2-ylcarbonyl)thioureato-κ2O,S]copper(II)
  262. THE CRYSTAL STRUCTURE OF A MICROLITE-GROUP MINERAL WITH A FORMULA NEAR NaCaTa2O6F FROM THE MORRO REDONDO MINE, CORONEL MURTA, MINAS GERAIS, BRAZIL
  263. Study of the phenanthroline-Mn-imidazole bonding in Mn(I) triscarbonyl complex: A X-ray and DFT computational analysis
  264. cis-Bis{1,1-dibenzyl-3-[(furan-2-yl)carbonyl]thioureato-κ2O,S}nickel(II)
  265. Tetrachlorocarbonyliridates: Water-Soluble Carbon Monoxide Releasing Molecules Rate-Modulated by the Sixth Ligand
  266. Synthesis and Crystal Structures of Octahedral Sn(IV) Complexes Prepared from SnCl2·2H2O and 2-Hydroxyacetophenone (S-benzydithiocarbazate) Ligand (H2L)
  267. 4-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoic acid: X-ray and DFT-calculated structure
  268. Design of 1D and 2D molecule-based magnets with the ligand 4,5-dimethyl-1,2-phenylenebis(oxamato)
  269. Increasing the symmetry of drug crystals: a monoclinic conformational polymorph of the platelet antiaggregating agent ticlopidine hydrochloride
  270. The mer-[RuCl3(dppb)(H2O)] complex: A versatile tool for synthesis of RuII compounds
  271. 2-(Phenylcarbonothioylsulfanyl)acetic acid
  272. 3-Nitrophenol–4,4′-bipyridylN,N′-dioxide (2/1): a DFT study and CSD analysis of DPNO molecular complexes
  273. Triple Structural Transition below Room Temperature in the Antifilarial Drug Diethylcarbamazine Citrate
  274. Coordination of nitro-thiosemicarbazones to ruthenium(II) as a strategy for anti-trypanosomal activity improvement
  275. On the synthesis and structures of the complexes [RuCl(L)(dppb)(N–N)]PF6 (L=CO, py or 4-NH2py; dppb=1,4-bis(diphenylphosphino)butane; N–N=2,2′-bipyridine or 1,10-phenanthroline) and [(dppb)(CO)Cl2-Ru-pz-RuCl2(CO)(dppb)] (pz=pyrazine)
  276. Oxorhenium(V) Complexes with 2,3-Dihydroxynaphthalene
  277. 2-[(2-Carboxyphenyl)disulfanyl]benzoic acid–4,4′-bipyridylN,N′-dioxide (1/2)
  278. ChemInform Abstract: 6-Deoxyjacareubin.
  279. ChemInform Abstract: Serendipitous, One-Pot Formation of 2,3,7-Triphenylcyclopenta[c]pyran from 1,2-Diphenylethanedione (“Benzil”) and Cyclopentadiene.
  280. Synthesis, characterization and cytotoxic activities of the [RuCl2(NO)(dppp)(L)]PF6 complexes
  281. Solvothermal Preparation of Drug Crystals: Didanosine
  282. From Rational Design of Drug Crystals to Understanding of Nucleic Acid Structures: Lamivudine Duplex
  283. Structural and magnetic properties of the oxyborateCo5Ti
  284. On the relationships between molecular conformations and intermolecular contacts toward crystal self-assembly of mono-, di-, tri-, and tetra-oxygenated xanthone derivatives
  285. Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity
  286. Dependence of the product on the P–P ligand in reactions of [RuCl3(NO)(P–P)] complexes (P–P=aromatic diphosphines) with 2-mercaptopyridine
  287. Experimental and theoretical study of the kinetics of dissociation in cis-[RuCl2(P-P)(N-N)] type complexes
  288. Efficient synthesis of benzothiazine and acrylamide compounds
  289. A novel and simple synthetic route for a piperazine derivative
  290. Palladium(II) complexes with thiosemicarbazones: syntheses, characterization and cytotoxicity against breast cancer cells and Anti-Mycobacterium tuberculosis activity
  291. Crystal Engineering of an Anti-HIV Drug Based on the Recognition of Assembling Molecular Frameworks
  292. Structural relationships in the solid state of the anti-chagas agent (E)-phenylethenylbenzofuroxan
  293. Driving forces in substitution reactions of octahedral complexes: The influence of the competitive effect
  294. Synthesis, structural characterization and ex vivo biological properties of a new complex [Cu(propranolol)2]·2H2O, a potential beta-blocker
  295. Imidazolium fumarate
  296. Heterobimetallic compounds [Ru(η5-Cp)(dppf)X] (X = Cl, Br, I and N3): synthesis, electrochemical analysis, and the crystal structure of [Ru(η5-Cp)(dppf)I] [dppf = 1,1′-bis(diphenylphosphino)ferrocene]
  297. Bis(tetraphenylphosphonium) tris[N-(methylsulfonyl)dithiocarbimato(2−)-κ2S,S′]stannate(IV)
  298. Synthesis, characterization, and single crystal X-ray structure of the 1-furoyl-3-cyclohexylthiourea cadmium chloride complex, Cd[C4H3OC(O)NHC(S)NHC6H11]4Cl2
  299. Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C
  300. Conformational Polymorphism in Racemic Crystals of the Diuretic Drug Chlortalidone
  301. 3-Nitrobenzoic acid–3-methyl-4-nitropyridine 1-oxide (1/1)
  302. On an Electrode Modified by a Supramolecular Ruthenium Mixed Valence (Ru II /Ru III ) Diphosphine-Porphyrin Assembly
  303. Molecular conformation of the racemic indan derivative (±)-1-trans-3-(3,4-dichlorophenyl)-2,3-dihydro-1H-indene-1-carboxamide
  304. 4-{2-[4-(Dimethylamino)phenyl]ethylidene}benzonitrile
  305. Partial magnetic ordering and crystal structure of the ludwigitesCo2
  306. 1-Furoyl-3-[3-(trifluoromethyl)phenyl]thiourea
  307. Diphenyllead(IV) thiosemicarbazonates and pyrazolonates: Synthesis and characterization
  308. Redetermination of 1-benzyl-3-furoyl-1-phenylthiourea
  309. Preparation of Achiral and Chiral (E)-Enaminopyran-2,4-diones and Their Phytotoxic Activity
  310. Spectroscopic Investigation on the Formation of a Dinuclear Me2SO–Ru2-Mercaptopyridine Bridged Complex: [Ru2Cl3(μ-pyS)(μ-dmso)(dmso)4] · 2H2O
  311. Lupeol
  312. Vanadium complexes with thiosemicarbazones: Synthesis, characterization, crystal structures and anti-Mycobacterium tuberculosis activity
  313. Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: Orally effective anti-inflammatory drug candidates
  314. Synthesis, structural characterization and conformational aspects of nostoclide analogues
  315. Organotin Complexes of Alizarin and Purpurin
  316. Different coordination modes for disulfoxides towards diorganotin(IV) dichlorides. X-ray crystal structures of 1,2-cis-bis-(phenylsulfinyl)ethene (rac-,cis-cbpse) and adducts [{Ph2SnCl2(meso-bpse)}n] and [{n-Bu2SnCl2(pdtd)}2]
  317. Study of the [Zn(H2O)4CuEDTA]·2H2O Complex, a Potential Trace-metal Supplier: Synthesis, Crystal Structure, Spectroscopic Behavior and Metal Release
  318. Analyzing Ru(III)–dmso and Ru(III)–dms motifs in compounds used in the synthesis of the antimetastatic agents
  319. N-(4-Chlorophenyl)maleimide
  320. Rhenium chelate complexes with maltolate or kojate
  321. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the “SpymMe2” ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine
  322. Powder X-ray diffraction study of polymorphic drugs: fluconazole and mebendazole
  323. 1-(o-Tolyl)thiourea
  324. N-(2-Furylcarbonyl)piperidine-1-carbothioamide
  325. 1-(2-Furoyl)-3-(o-tolyl)thiourea
  326. Crystal Structure of Garciniaphenone and Evidences on the Relationship between Keto-Enol Tautomerism and Configuration
  327. Hydrogen bonding in 2-(2-oxothiazolidin-3-yl)-4,5-dihydrothiazolium hydrogen sulfate monohydrate
  328. 1-(3-Cyanophenyl)-3-(2-furoyl)thiourea
  329. Quantum-chemical, NMR and X-ray diffraction studies on (±)-1-[3,4-(methylenedioxy)phenyl]-2-methylaminopropane
  330. 1-Furfuryl-3-furoylthiourea
  331. Structure and magnetism of homometallic ludwigites:Co3O
  332. Synthesis and Characterization of a New Copper(II) Complex with Nadolol, an Aminoalcoholic Beta-blocker. Crystal Structure of Na[Cu(nadololate)(CO3)] · H2O
  333. N-(3-Chlorophenyl)maleimide
  334. 8-Hydroxy-5,6,7-trimethoxy-2-phenyl-4H-chromen-4-one
  335. Lead(II)-induced formation and coordination of 3,4-dihydro-3-thioxo-1,2,4-triazin-5(2H)-one
  336. Dimethylthallium(III) complexes with picolinic acid and its hydroxyl derivatives
  337. Ruthenium(II) complexes containing N(4)-tolyl-2-acetylpyridine thiosemicarbazones and phosphine ligands: NMR and electrochemical studies of cis–trans isomerization
  338. Crystal Structures and Thermal Behavior of Alkaline Earth Tricyanomethanides
  339. New Ni(II)-sulfonamide complexes: Synthesis, structural characterization and antibacterial properties. X-ray diffraction of [Ni(sulfisoxazole)2(H2O)4]·2H2O and [Ni(sulfapyridine)2]
  340. Menezesite, the first natural heteropolyniobate, from Cajati, Sao Paulo, Brazil: Description and crystal structure
  341. Synthesis and Characterization of a New Mebendazole Salt: Mebendazole Hydrochloride
  342. New insights on the Lewis acidity of diorganolead(IV) compounds: Diphenyllead(IV) complexes with N,O,S-chelating ligands
  343. Synthesis of novel O-acylated-D-ribono-1,5-lactones and structural assignment supported by conventional NOESY-NMR and x-ray analysis
  344. Sobre uma degenerescência acidental nos deslocamentos químicos de RMN de 31P{¹H} em complexos difosfínicos de rutênio
  345. Crystalline Structure of Mangiferin, aC-Glycosyl-Substituted 9H-Xanthen-9-one Isolated from the Stem Bark ofMangifera indica
  346. New Pd(II) and Pt(II) complexes with N,S-chelated pyrazolonate ligands: Molecular and supramolecular structure and preliminary study of their in vitro antitumoral activity
  347. Novel manganese (III) porphyrin containing peripheral “[RuCl(dppb)(X-bipy)]+” cations [dppb=1,4-bis(diphenylphosphino)butane and X=–CH3, –OMe, –Cl]. X-ray structure of the cis-[RuCl(dppb)(bipy)(4-Mepy)]PF6 complex
  348. Low-temperature study of a new nevirapine pseudopolymorph
  349. 2-Benzoylpyridine semicarbazone
  350. Synthesis, characterization and crystal structure of a novel thiocyanate–ruthenium(II) complex
  351. Heterobimetallic [Ru(II)/Fe(II)] complexes: On the formation of trans- and cis-[RuCl2(dppf)(diimines)]
  352. Synthesis, characterization, X-ray structure and preliminary in vitro antitumor activity of the nitrosyl complex fac-[RuCl3(NO)(dppf)], dppf=1,1′-bis(diphenylphosphine)ferrocene
  353. Crystal structure, electrochemical and photochemical studies of the trans-[Fe(cyclam)(NO)Cl]Cl2 complex (cyclam=1,4,8,11-tetraazacyclotetradecane)
  354. New lead(II) complexes with N,S-ligands, including a lead pyrazolonate with unusual packing flexibility
  355. Crystal structure and anticonvulsant activity of (±)-1,2:4,5-di-O-isopropylidene-3,6-di-O-(2-propylpentanoyl)-myo-inositol
  356. X-ray structure and EPR behavior of a new dimeric copper(II) complex with 4-amino-N-(5-methoxy-2-pyrimidinyl)benzenesulfonamide
  357. Methyllead(IV) Derivatives Stabilized by DAPTSC2–: Synthesis and Structures of New Diorganolead(IV) Complexes
  358. Novel Gold(I) 7-Azacoumarin Complex:  Synthesis, Structure, Optical Properties, and Cytotoxic Effects
  359. Synthesis and structural characterization of two nostoclide analogues
  360. Correlation between quadrupole splitting (Δ) and the θ angle (C–Sn–C) in five-coordinate diphenyltin(IV) complexes. X-ray crystal structures of [Ph2Sn(hacm)] and [Ph2Sn(hacmm)] containing O,N,S-tridentate N 4-heterocyclic thiosemicarbazones
  361. 2,2′,4-Trihydroxybenzophenone: Crystal Structure, and Anti-Inflammatory and Antioxidant Activities
  362. Physicochemical characterization of deflazacort: Thermal analysis, crystallographic and spectroscopic study
  363. The preparation of new oxoniobium(V) complexes from hydrated Niobium(V) Oxide: the crystal and molecular structure of Oxotris(2-pyridinolato-N-oxide)niobium(V)
  364. Pseudohalides of Main Group Metals: The Alcaline Earth Tricyanomethanides - The Crystal Structures of Calcium and Barium Tricyanomethanide.
  365. Natural polyprenylated benzophenones: keto-enol tautomerism and stereochemistry
  366. The first P–N containing RuCl3NO complex: fac-[RuCl3(NO)(P–N)] (P–N=[o-(N,N-dimethylamino)phenyl]diphenylphosphine)
  367. Novel zwitterionic oxorhenium(V) complexes: synthesis, characterization and crystal structure of [ReOX2(Hdhp)(PPh3)] (X = Cl, Br; H2dhp = 2,3-dihydroxypyridine)
  368. Matioliite, the Mg-analog of burangaite, from Gentil mine, Mendes Pimentel, Minas Gerais, Brazil, and other occurrences
  369. A gold(I) complex with a vitamin K3 derivative: Characterization and antitumoral activity
  370. 7-Amino-1-(3-bromophenyl)-3-cyanopyrazolo[4,3-d]pyrimidine
  371. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests
  372. Structural characterization of a series of new Cu-dipeptide complexes in solid state and in solution
  373. Magnetic properties of copper(II) complexes containing peptides. Crystal structure of [Cu(phe-leu)]
  374. Synthesis, 119Sn Mössbauer spectroscopic studies and X-ray crystal structure determination of new seven-coordinate diorganotin(IV) complexes with S,N,N,N,S-pentadentate Schiff bases derived from 2,6-diacetylpyridine of S-methyl- and S-benzyldithiocarba...
  375. On a ruthenium nitrosyl and monocoordinated biphosphine monoxide complex: Synthesis, characterization and X-ray structure of
  376. Preparation, crystal structure and spectroscopic characterization of nickel(II) complexes with dithiocarbimate derivated of sulfonamides
  377. Copper complexes with heterocyclic sulfonamides: Synthesis, spectroscopic characterization, microbiological and SOD-like activities: Crystal structure of [Cu(sulfisoxazole)2(H2O)4]·2H2O
  378. Structure and Vasorelaxant Activity of Floranol, a Flavonoid Isolated from the Roots ofDioclea grandiflora
  379. Influence of ligands on the isomerization in [RuCl3(NO)(P–P)] complexes, [P–P=R2P(CH2)nPR2 (n=1–3) and R2P(CH2)POR2, PR2–CHCH–PR2, R=Ph and (C6H11)2P-(CH2)2-P(C6H11)2]
  380. Mammeigin
  381. Polymorphism on Leflunomide: Stability and Crystal Structures
  382. The versatility of the 1,4-dithiane ligand towards the coordination chemistry of ruthenium-phosphine complexes
  383. The role of solvent in coordination polymers: The structures of catena-[Hg(μ2-O2PPh2)2] and catena-[Hg(μ2-O2PPh2)2(NC5H5)2]
  384. Experimental and theoretical structure characterization of two isoniazid derivatives: 2,4-Difluoro-N′-isonicotinoylbenzohydrazide and 2,4-dichloro-N′-isonicotinoylbenzohydrazide hydrochloride
  385. Ruthenium Phosphine/Diimine Complexes: Syntheses, Characterization, Reactivity with Carbon Monoxide, and Catalytic Hydrogenation of Ketones.
  386. Bis(diphenylphosphinato-κO)bis(diphenylphosphinic acid-κO)bis(pyridine-κN)mercury(II)
  387. Mono- and dinuclear copper(I) complexes with methyl-substituted pyrimidinethiones
  388. A pentacyclic triterpene from Maytenus imbricata: structure elucidation by X-ray crystallography
  389. Synthesis, characterisation and molecular structure of stannyl derivatives of molybdenum and iron
  390. Zinc(II), cadmium(II) and mercury(II) complexes of the vitamin B1 antagonist oxythiamine
  391. Synthesis, characterization and structure of ruthenium(II) phosphine complexes with N-heterocyclic thiolate ligands
  392. A Crystalline Phase Transition and Optical Properties in a CoIICuII Oxamato-Bridged Ferrimagnetic Chain
  393. Ruthenium Phosphine/Diimine Complexes:  Syntheses, Characterization, Reactivity with Carbon Monoxide, and Catalytic Hydrogenation of Ketones†
  394. The RuCl3(dppb)H2O complex: A new metal-assisted oxidative dehydrogenation of the o-phenylenediamine ligand
  395. Leaf-cutting ants toxicity of limonexic acid and degraded limonoids from Raulinoa echinata.: X-ray structure of epoxy-fraxinellone
  396. Limonoids from Spiranthera odoratissima St. Hil
  397. Synthesis and characterization of nitrosyl complexes containing 4,6-dimethyl-pyrimidine-2-thiolato (‘SpymMe2’) as ligand: [Ru(‘SpymMe2’,-N,-S) (‘SpymMe2’,-S)(NO)(P–P)](PF6) (P–P=1,2-bis(diphenylphosphino)ethane or 1,2-bis(diphenylphosphino)ethylene
  398. Magnetic and structural properties of two open-frameworks Nd(III) adipates
  399. Structural insights of a potential inhibition against leishmania major
  400. Factors determining polymorphism of leflunomide
  401. Magnetic and structural properties of rare earth hybrid frameworks
  402. Experimental electron density of [Cu(phen)2Cl](NO3)(H2O)
  403. An Alternative Method for the Preparation of Diphenylboron Chelates. The Crystal and Molecular Structures of (Pyridine-2-acetyloximato)diphenylboron and (1-Phenylazo-2-naphtholato)diphenylboron
  404. Molecular and Supramolecular Structures of 1-Phenyl-4-phenylacetyl-2-thiosemicarbazide (H2L) and its Complexes with Diphenyllead(IV) Chloride and Acetate
  405. Electron density distribution in the pyroborateMn2B...
  406. 5-Nitro-2-furaldehydeN-(hydroxymethyl)semicarbazone
  407. Ruthenium complexes containing the hemilabile ligand PPh2(CH2)P(O)PPh2 (dppmO): reactivity towards CO and X-ray molecular structures of tcc-RuCl2(η2-dppmO)2 and mer-RuCl3(η1,η2-dppmO)2
  408. New pyrone and quinoline alkaloid from Almeidea rubra and their trypanocidal activity
  409. The synthesis and characterisation of Sn(IV) complexes of 2,6-pyridine dicarboxylate — the molecular structure of divinyltin(IV) derivative
  410. Layered poly[μ2-aqua-μ3-dimethylformamide-di-μ3-phenylphosphonato-dipotassium]
  411. Synthesis, characterization, and structure of a new N-nitrosamine of cyclam (1,4,8,11-tetraazacyclotetradecane)
  412. 31P{1H}-n.m.r. as a tool for identification of ruthenium isomers containing PPh3 or 1,4-bis(diphenylphosphino)butane ligands. X-ray structures of the cis-{RuCl2(PPh3)2 [4,4′-(-X)2-2,2′-bipy]} complexes [X=-H, -Me, -SMe and (-Cl, -Me)]
  413. Candesartan cilexetil, an antihypertensive agent containing an extended double ester chain
  414. mer-[RuCl3(P–P)H2O] (P–P=dppb or diop) as a starting material for the synthesis of binuclear complexes. Crystallographic structures of [(dppb)ClRu–μ(Cl)3–RuCl(dppb)] and [(η6-C6H6)Ru–μ(Cl)3–RuCl(dppb)].Imine hydrogenation using mono- and binuclear ruth...
  415. Polymeric chains, hydrogen bonds and magnetism in Nd(III) adipates
  416. Aurapten, a coumarin with growth inhibition against Leishmania major promastigotes
  417. Neo-clerodane diterpenoid, a new metalloprotease snake venom inhibitor from Baccharis trimera (Asteraceae): anti-proteolytic and anti-hemorrhagic properties
  418. mer-[RuCl3(P–P)H2O] (P–P=dppb or diop) as a starting material for the synthesis of binuclear complexes. Crystallographic structures of [(dppb)ClRu–μ(Cl)3–RuCl(dppb)] and [(η6-C6H6)Ru–μ(Cl)3–RuCl(dppb)].
  419. Syntheses, characterization and X-ray structure of potassium hydrotris(2-mercaptothiazolyl)borate, KMt, and potassium hydrotris(methimazole)borate, KTm
  420. N2,S-versus N3,S-coordination in thiosemicarbazonate complexes: only a steric influence?
  421. Crystal structure and spectral characterization of dimethylthallium (III) complexes with 2-mercaptonicotinic acid and esters
  422. The effect of the cation substitution on the structural and vibrational properties of Cs2NaGaxSc1−xF6 solid solution
  423. Crystal structure and vibrational spectrum of the NaCaMg2F7 pyrochlore
  424. The synthesis and structural characterisation of [Ru(η-Cp)(dppf)SnBr3]
  425. Synthesis, characterisation and thermal decomposition of tin(IV) dithiocarbamate derivatives – single source precursors for tin sulfide powders
  426. Synthesis, Structural, Spectroscopic and Electrochemical Characterization of New Ruthenium(II) Tetramer Complexes Containing 1,4-Bis(diphenylphosphine)butane and Alterdentate Ligands
  427. Reaction of R(Ph)SnCl2(R=Me, Et) with 2,6-diacetylpyridine bis(thiosemicarbazone) (H2DAPTSC): the crystal structures of [Me(Ph)Sn(HDAPTSC)]Cl·1.25 MeOH and [Et(Ph)Sn(H2DAPTSC)]Cl2·MeOH·H2O
  428. Crystallographic report: Supramolecular structure of 2-aminonicotinatodimethylthallium(III),[TlMe2(2anic)]n
  429. Preparation, crystal structure and spectroscopic characterization of novel N-R-sulfonyldithiocarbimate platinum(II) complexes
  430. The Reaction of Dimethyltin(IV) Dichloride with Thiamine Diphosphate (H2TDP):  Synthesis and Structure of [SnMe2(HTDP)(H2O)]Cl·H2O, and Possibility of a Hitherto Unsuspected Role of the Metal Cofactor in the Mechanism of Vitamin-B1-Dependent Enzymes
  431. Structural, spectroscopic and redox studies of a new ruthenium(III) complex with an imidazole-rich tripodal ligand
  432. The Zn2+salt of pamidronate: a role for water in the metal–cation binding properties of bisphosphonates
  433. Crystallographic report: Ethyltriphenyltin(IV), Et(Ph)3Sn
  434. Potassium tetrakis(2-mercaptothiazolyl)borate; an open-framework material: synthesis and X-ray structure analysis
  435. A new monoclinic polymorph of methylp-aminobenzoate
  436. New thallium(III) chloride complexes with pyridine carboxylic acids: from molecular compounds to supramolecular associations
  437. Synthesis, crystal structures and spectroscopic properties of dichloroethylphenyltin(IV) and its phenanthroline adduct
  438. Dichloro(diphosphine)(2-pyridyl-ketone)ruthenium(II) complexes
  439. New Crystals in the Lithium Sulfate Family.
  440. 3-(5,7-Dimethoxy-2,2-dimethyl-2H-benzo[b]pyran-6-yl)propionic acid: a potential inhibitor against Leishmania
  441. Redetermination of skimmianine: a new inhibitor against the Leishmania APRT enzyme
  442. Redetermination and comparative structural study of isopimpinellin: a new inhibitor against the Leishmania APRT enzyme
  443. New crystals in the lithium sulfate family
  444. Design, Synthesis, and Evaluation of Analogues of 3,3,3-Trifluoro-2-Hydroxy-2-Phenyl-Propionamide as Orally Available General Anesthetics
  445. 3-(Benzoxazol-2-yl)-7-hydroxychromen-2-one methanol solvate
  446. Two members of the bisphosphonate class of drugs: a zwitterion and a molecular compound
  447. 2-Cyano-N-(2-hydroxyphenyl)acetamide
  448. Compositional and Structural Variety of Diphenyllead(IV) Complexes Obtained by Reaction of Diphenyllead Dichloride with Thiosemicarbazones
  449. Structure and magnetism ofMnMgB2
  450. 17α,21-Dihydroxy-16β-methylpregna-1,4-diene-3,11,20-trione (meprednisone)
  451. 4-(2-Isonicotinoylhydrazino)-4-oxobutanoic acid
  452. Synthesis and characterization of new ruthenium complexes with active ligands against Chagas' disease
  453. Redetermination of nickel bis(dithiocarbamate) at 100 K
  454. Synthesis, Spectroscopic and Structural Aspects of Mono‐ and Diorganothallium(III) Complexes of 2, 6‐Diacetylpyridine Bis(thiosemicarbazone) (H2DAPTSC) — A New Coordination Mode of the HDAPTSC— Anion
  455. 3-Oxoolean-12-en-20-yl α-methylcarboxylate
  456. A novel diterpene lactone
  457. fac-[RuCl3(NO)(dppb)] (I) and mer-[RuCl3(NO)(diop)] (II) complexes: syntheses, characterization and X-ray structures
  458. Novel Organophosphorus Cage Compound Produced by an Unexpected Oxidative Coupling of 1,2,4-Triphosphole: Crystal and Molecular Structures of Two Isomers of Formula P6C4Bu t4 CHSiMe3
  459. Syntheses, characterization and X-ray structures of the fac-[RuCl3(NO)(dppe)] and the trans-[RuCl(NO)(dppe)2]2+ species
  460. Charge density study of hexaaquazinc(II) dihydrogen-1,2,4,5-benzenetetracarboxylate
  461. Supramolecular organization in ruthenium complexes
  462. Supramolecular arrangement in dimethyl thallium complexes through Tl...S
  463. Crystal structure of cobalt-based chain molecular magnet CoCu(opba)(DMSO)3at room temperature and 100 K
  464. New Cages Derived from 1,2,4-Triphosphol
  465. Losartan potassium, a non-peptide agent for the treatment of arterial hypertension
  466. On the lability of dimethylsulfoxide (DMSO) coordinated to the {RuII–NO+} species: X-ray structures of mer-[RuCl3(DMSO)2(NO)] and mer-[RuCl3(CD3CN)(DMSO)(NO)]
  467. Single-crystal structure determination and infrared reflectivity study of the Li2CaHfF8 scheelite
  468. Crystal structure, electrochemical and spectroscopic properties of the trans-K{[FeCl(NO0)(cyclam)]·[FeCl(NO+)(cyclam)]2}(PF6)6 complex
  469. Metal-Induced Cyclization of Thiosemicarbazones Derived from β-Keto Amides and β-Keto Esters:  Open-Chain and Cyclized Ligands in Zinc(II) Complexes
  470. Supramolecular self-assembly in the crystal structures of methylmercury xanthates, MeHgS(S)COR, R=Et, iPr and CH2Ph
  471. Disodium pamidronate
  472. Synthesis and structure of cadmium and zinc complexes of dehydroacetic acid
  473. Epikatonic acid fromAustroplenckia populnea: structure elucidation by 2D NMR spectroscopy and X-ray crystallography
  474. Serendipitous, one-pot formation of 2,3,7-triphenylcyclopenta[c]pyran from 1,2-diphenylethanedione (“benzil”) and cyclopentadiene
  475. Structural Transition and Pair Formation inFe3
  476. 6-Deoxyjacareubin
  477. 1-(2-{4-[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiol-3-ylcarbonyl]phenoxy}ethyl)piperidinium chloride
  478. Role of the Hydrogen Bonds in Nitroanilines Aggregation:  Charge Density Study of 2-Methyl-5-nitroaniline
  479. A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl2(NO)L] (I) and [RuCl2(NO)L]·DMSO (II) (L = [(2-py)2PC2H4POO(2-py)2]-)
  480. Structure and properties of iron–cyclam complex of 2-aminophenol
  481. THE CRYSTAL STRUCTURE OF DICHLORODIPHENYLBIPYRIDINE LEAD(IV), [PbPh2Cl2(bipy)]
  482. THE CRYSTAL STRUCTURE OF DIBROMOBIPYRIDINELEAD(II), [PbBr2(bpy)]
  483. THE CRYSTAL STRUCTURE OF DICHLORODIPHENYLPHENANTHROLINELEAD(IV), [PbPh2Cl2(phen)]
  484. Crystal structure and exchange pathways of the complex l-(trypthophyl-glycinato)copper(II)
  485. A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl2(NO)L] (I) and [RuCl2(NO)L]·DMSO (II) (L = [(2-py)2PC2H4POO(2-py)2]-)
  486. Hydrogen Bonding in Nitroanilines:  Neutron Diffraction Study of m -Nitroaniline at 100 K
  487. Electrosynthesis of binuclear ruthenium complexes from [RuCl3(dppb)(L)] precursors [L = pyridine, 4-methylpyridine or dimethyl sulfoxide; dppb = 1,4-bis(diphenylphosphino)butane]
  488. Crystal structures of p-chlorobromobenzene and p-chloroiodobenzene
  489. Ba2Cu(HCOO)6, Thermal Behavior and Crystal Structure of the Room Temperature Phase
  490. Experimental evidence for the amino-group non-planarity in nitroanilines: neutron diffraction study of 2-methyl-5-nitroaniline at 100 K
  491. 3-Aryloxypropiononitriles Intermediates: Crystal and Molecular Structure of 2- and 4-(2-Bromoethoxy)diphenylmethanes
  492. 3-Aryloxypropiononitriles Intermediates: Crystal and Molecular Structure of 2- and 4-(2-Bromoethoxy)diphenylmethanes
  493. 2,4-Dinitro-N,N-methylphenylaniline
  494. 4-Benzyl-5-ethylthio-3H-1,2-dithiole-3-thione
  495. 2,4-Dinitrophenyl Phenyl Sulfone
  496. 4-Methyl-2-nitroaniline
  497. Structural studies of intermediates in a novel synthesis of aryloxypropiononitriles
  498. Conformational studies of substituted nitroanilines: geometry of 2-methyl-5-nitroaniline
  499. X-ray structural and spectroscopic investigation of 1-piperidine-2,4-dinitrobenzene